Fulton Breakefield Broenniman’s iShares iBonds Dec 2022 Term Corporate ETF IBDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-203,787
Closed -$5.1M 178
2022
Q3
$5.1M Sell
203,787
-9,373
-4% -$234K 0.48% 63
2022
Q2
$5.33M Sell
213,160
-4,101
-2% -$103K 0.46% 63
2022
Q1
$5.44M Buy
217,261
+665
+0.3% +$16.7K 0.48% 57
2021
Q4
$5.45M Buy
216,596
+6,281
+3% +$158K 0.4% 61
2021
Q3
$5.33M Buy
210,315
+7,078
+3% +$179K 0.46% 58
2021
Q2
$5.16M Buy
203,237
+28,359
+16% +$721K 0.44% 59
2021
Q1
$4.45M Buy
174,878
+81,462
+87% +$2.08M 0.41% 58
2020
Q4
$2.39M Sell
93,416
-57,925
-38% -$1.48M 0.29% 59
2020
Q3
$3.88M Buy
151,341
+13,350
+10% +$342K 0.44% 53
2020
Q2
$3.54M Buy
137,991
+25,489
+23% +$647K 0.43% 55
2020
Q1
$2.79M Buy
112,502
+13,318
+13% +$334K 0.42% 55
2019
Q4
$2.51M Buy
99,184
+6,697
+7% +$169K 0.29% 65
2019
Q3
$2.34M Buy
+92,487
New +$2.33M 0.3% 67

Other funds holding IBDN

Fulton Breakefield Broenniman's IBDN Position: Q4 2022 in Review

Fulton Breakefield Broenniman sold out of iShares iBonds Dec 2022 Term Corporate ETF (IBDN) in Q4 2022, closing a stake of 203,787 shares — an estimated $5.1M sold.

Fulton Breakefield Broenniman first reported a position in IBDN in Q3 2019 and held it in 13 quarters. The position peaked at $5.45M in Q4 2021. 2 funds tracked by Wall St. Rank hold IBDN as of Q4 2022.

  • Fulton Breakefield Broenniman reported no remaining iShares iBonds Dec 2022 Term Corporate ETF position as of Q4 2022 after selling out during the quarter.
  • Fulton Breakefield Broenniman sold 203,787 iShares iBonds Dec 2022 Term Corporate ETF shares in Q4 2022, an estimated $5.1M.
  • Fulton Breakefield Broenniman first reported a position in iShares iBonds Dec 2022 Term Corporate ETF in Q3 2019 and held it in 13 quarters.
  • Fulton Breakefield Broenniman's iShares iBonds Dec 2022 Term Corporate ETF position peaked at $5.45M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held iShares iBonds Dec 2022 Term Corporate ETF as of Q4 2022.

Based on Fulton Breakefield Broenniman's 13F filing for Q4 2022, filed 31 Jan 2023.